课题基金 / 基金详情

Analysis of Immunodeficiencies with defective DNA damage response

Analysis of Immunodeficiencies with defective DNA damage response
DNA 损伤反应缺陷的免疫缺陷分析
批准号:
18591184
负责人:
MORIO Tomohiro
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

MORIO Tomohiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We sought to analyze molecular mechanism of immunodeficiency caused by defective DNA damage response working on cells from disorders including ataxia-telangiectasia (AT), Artemis deficiency, and Nijmegen breakage syndrome (NBS1 deficiency).We have so far revealed that S645 of Artemis is phosphorylated by ATM upon DNA damaging reagent. Through this study, we have shown 70-kDa molecule is associated with Artemis and controls stability of Artemis. The interaction requires phosphorylation of Artemis, but the site is not in the hitherto-known region. A new role of Artemis was also demonstrated. Endonuclease activity of Artemis was shown to be required for double strand DNA break when DNA replication is stalled in a ragging strand. This process was dependent on ATM. Further investigation is currently in progress.DNA damage response (DDR) is absolutely required for diversification of immune receptors; and disrupted DDR during the process leads to chromosomal aberration. We analyzed involvement of the DDR molecules in tumorigenesis, and found that DDR is activated in pre-malignant stage. The loss of DDR led to malignant transformation of the cells with mutation in p53 in some cases (Leukemia 2006).ATM and Ku70/80 were shown to be degraded upon oxidative stress leading to cellular apoptosis (Ann NY Acad Sci 2006, Int J Biochem Cell Biol. 2008)。 The cells escaped from apoptosis may lead to acquisition of chromosomal aberration.We diagnosed 14 patients with AT, 2 DNA ligase IV deficiency, 2 Mre11deficiency (ATLD) and one Cernunnos deficiency. Finally, we carried out the first nation-wide survey for AT. We observed phenotypic variety between sibling cases with AT. Hyper-IgM was noted in 10% of the patients indicating involvement of ATM in class switch recombination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cell.2007.12.037
发表时间: 2008-03-07
期刊: CELL
影响因子: 64.5
作者: [Shinohara, Masahiro, Koga, Takako, Takayanagi, Hiroshi]
通讯作者: Takayanagi, Hiroshi
Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide
接触过氧化氢的人成纤维细胞中共济失调毛细血管扩张突变依赖性 Ku 激活
DOI: --
发表时间: 2006
期刊: Ann N Y Acad Sci 1091
影响因子: --
作者: [Lee JH, Kim KH, Morio T, Kim H.]
通讯作者: Kim H.
関連学会合同シンポジウム「細胞移植・再生医療における品質管理のあり方」細胞移植の立場から(増殖リンパ球治療を中心として)
相关学会联合研讨会:从细胞移植的角度看“细胞移植与再生医学的质量控制应该如何”(聚焦增殖淋巴细胞治疗)
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [森尾友宏, 清水則夫, 伊藤仁也]
通讯作者: 伊藤仁也
骨髄異形成症候群(MDS)の白血病への進展過程におけるDNA損傷応答の関与
DNA 损伤反应参与骨髓增生异常综合征 (MDS) 向白血病的进展
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [高木正稔, 堀部志保, 森尾友宏, 北川昌伸, 水谷修紀]
通讯作者: 水谷修紀
38
    Study on pathogenesis of disorders caused by neutrophil dysfunction using novel analytical techniques and development of an innovative strategy to control neutrophils
    • 批准号:
      25670472
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    Research on molecular mechanisms of break in immunological tolerance in disorders caused by single-gene defect
    • 批准号:
      23390270
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2011
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    Study on molecules that negatively regulate ROS production in human granulocyes
    • 批准号:
      23659518
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    Study on the mechanism of autoimmunity and malignancy developed in primary immunodeficiency
    • 批准号:
      20591245
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      MORIO Tomohiro
    • 依托单位:
    海外基金